Product category: Rapid tests in clinical chemistry
Product Features Diazyme's Ferritin Assay is a dual liquid stable reagent system. The method requires only 10 μL of sample, completed in less than 10 minutes, and has excellent correlation with existing commercial products with R2 of 0.9994, a slope of 1.007 and a y intercept of -11.74. The assay has within-run precision values of less than 4.1% and a total precision value less than 9.5%.
Assay Principle The Diazyme Ferritin Assay is based on a latex enhanced immunoturbidimetric assay. When an antigen-antibody reaction occurs between Ferritin in a sample and anti-Ferritin antibodies which have been sensitized to latex particles, agglutination occurs. This agglutination is detected as an absorbance change (560 nm), with the magnitude of the change being proportional to the quantity of Ferritin in the sample. The actual concentration is then determined from a calibration curve prepared from calibrators of known concentrations.
Intended use The Diazyme Ferritin Assay is for the quantitative determination of ferritin in serum and plasma samples. For in vitro diagnostic use only
Diazyme uses its proprietary enzyme technologies to develop diagnostic reagents which can be used on most automated chemistry analyzers in user-friendly formats. Diazyme's products include test kits for diagnosis of cardiovascular disease, liver disease, cancer markers, renal disease, diabetes, and electrolytes.
Diazyme Laboratories, an affiliate of General Atomics, is located in Poway, California and is a cGMP and ISO 13485 certified medical device manufacturer.